Transcriptional profiling of 5T33MM cells treated in vivo with quisinostat, decitabine or the combination.

ABSTRACT: Epigenetic modulating agents are under intense investigation for cancer therapy including multiple myeloma. In this study, we investigated the in vivo transcriptional response to epigenetic modulating agents in multiple myeloma using the 5T33MM model with the aim to identify potential clinical relevant mechanisms and/or biomarkers linked with the response to epigenetic modulating agents in vivo.

INSTRUMENT(S): 418 [Affymetrix]

ORGANISM(S): Mus musculus

SUBMITTER: Ken Maes 

PROVIDER: E-MTAB-3178 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress